Intranasal Ketamine for Depression in Adults: A Systematic Review and Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials

BACKGROUND: There is growing interest in glutamatergic agents as a treatment for depression, especially intranasal ketamine, which has become a hot topic in recent years. We aim to assess the efficacy and safety of intranasal ketamine in the treatment of major depressive disorder (MDD), especially t...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Dongjiao, Wei, Changwei, Wang, Jing, Wu, Anshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Psychology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204747/
https://www.ncbi.nlm.nih.gov/pubmed/34140915
http://dx.doi.org/10.3389/fpsyg.2021.648691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204747/
https://www.ncbi.nlm.nih.gov/pubmed/34140915
http://dx.doi.org/10.3389/fpsyg.2021.648691

Ejemplares similares